Drug Profile
Hepatitis C vaccine - Acambis
Alternative Names: ChimeriVax- Hepatitis CLatest Information Update: 04 Jul 2006
Price :
$50
*
At a glance
- Originator Acambis
- Class Hepatitis C vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 14 Jun 2006 No development reported - Preclinical for Hepatitis C in USA (unspecified route)
- 26 Jun 2002 This vaccine is still in active development
- 14 Feb 2001 Preclinical development for Hepatitis C in USA (Unknown route)